Citation Tools
PDFRegular and Young Investigator Award Abstracts
Clinical Trials In Progress
631 Phase I dose escalation study in patients with advanced solid tumors with ANV419, a novel fusion protein selective for IL-2Rβ/γ
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- 631 Phase I dose escalation study in patients with advanced solid tumors with ANV419, a novel fusion protein selective for IL-2Rβ/γ